BBI Detection specialises in the development and supply of innovative technologies for rapid sampling and identification of biological threats, explosives and narcotics for military, first responder and security markets. With secure facilities in the US and UK, and over 25 years’ experience in the development of assays, we are ideally placed to serve the needs of military and first responder markets worldwide.
Our Integrated Multiplex Assay and Sampling System – IMASS™ platform solves the problem of sampling and identification of biothreats and explosives in ‘white powder’ incidents, due to its patented ergonomic design. The device was originally conceived by a cross-functional team of engineers and scientists at DSTL (the UK’s Defence Science and Technology Laboratories), and BBI Detection have since obtained a licence from the UK Secretary of State for Defence to develop and manufacture the IMASS™ device.
BBI Detection also distributes a unique product portfolio of simple to use, rapid and low cost solutions for the presumptive identification of explosives and narcotics in a variety of scenarios such as screening at secure checkpoints or the assessment of suspect powders in clandestine labs.